Morgan Stanley’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500
Closed -$318 8210
2025
Q2
$318 Sell
500
-3,623
-88% -$2.33K ﹤0.01% 7512
2025
Q1
$3.31K Sell
4,123
-61
-1% -$49 ﹤0.01% 7082
2024
Q4
$3.14K Buy
4,184
+60
+1% +$67 ﹤0.01% 7108
2024
Q3
$5.53K Hold
4,124
﹤0.01% 6890
2024
Q2
$5.32K Hold
4,124
﹤0.01% 6836
2024
Q1
$4.99K Sell
4,124
-4,124
-50% -$3.75K ﹤0.01% 6891
2023
Q4
$4.87K Sell
8,248
-12,880
-61% -$18.4K ﹤0.01% 7012
2023
Q3
$52.6K Buy
21,128
+10,222
+94% +$34.8K ﹤0.01% 6150
2023
Q2
$54K Sell
10,906
-2,797
-20% -$14.2K ﹤0.01% 6182
2023
Q1
$62.1K Sell
13,703
-400
-3% -$2.17K ﹤0.01% 6201
2022
Q4
$48.8K Sell
14,103
-1,858
-12% -$8.84K ﹤0.01% 6302
2022
Q3
$93K Sell
15,961
-12,850
-45% -$78.3K ﹤0.01% 6116
2022
Q2
$137K Buy
28,811
+14,307
+99% +$68.3K ﹤0.01% 6102
2022
Q1
$96K Sell
14,504
-7,103
-33% -$49.4K ﹤0.01% 6334
2021
Q4
$213K Buy
21,607
+7,489
+53% +$82.7K ﹤0.01% 6027
2021
Q3
$182K Buy
14,118
+3,530
+33% +$47.9K ﹤0.01% 6052
2021
Q2
$173K Buy
10,588
+7,760
+274% +$135K ﹤0.01% 6084
2021
Q1
$56K Sell
2,828
-26,362
-90% -$592K ﹤0.01% 6303
2020
Q4
$604K Buy
29,190
+26,252
+894% +$499K ﹤0.01% 4959
2020
Q3
$50K Sell
2,938
-3,176
-52% -$63.6K ﹤0.01% 5723
2020
Q2
$142K Sell
6,114
-11,711
-66% -$257K ﹤0.01% 5232
2020
Q1
$276K Buy
17,825
+17,040
+2,171% +$327K ﹤0.01% 4726
2019
Q4
$30K Buy
+785
New +$16.2K ﹤0.01% 5998
2019
Q3
Sell
-16,675
Closed -$225K 6661
2019
Q2
$109K Buy
16,675
+12,703
+320% +$79.3K ﹤0.01% 5282
2019
Q1
$24K Sell
3,972
-31,976
-89% -$216K ﹤0.01% 5952
2018
Q4
$174K Buy
35,948
+2,602
+8% +$22.7K ﹤0.01% 5334
2018
Q3
$367K Sell
33,346
-2,602
-7% -$35.4K ﹤0.01% 5159
2018
Q2
$561K Sell
35,948
-16,755
-32% -$344K ﹤0.01% 5018
2018
Q1
$1.13M Buy
52,703
+11,632
+28% +$163K ﹤0.01% 4462
2017
Q4
$379K Buy
41,071
+17,761
+76% +$211K ﹤0.01% 5127
2017
Q3
$412K Buy
23,310
+6,940
+42% +$116K ﹤0.01% 4992
2017
Q2
$256K Sell
16,370
-3,718
-19% -$42.4K ﹤0.01% 5201
2017
Q1
$211K Sell
20,088
-16,649
-45% -$178K ﹤0.01% 5305
2016
Q4
$492K Buy
36,737
+34,042
+1,263% +$435K ﹤0.01% 4943
2016
Q3
$37K Buy
2,695
+2,311
+602% +$37.9K ﹤0.01% 5702
2016
Q2
$5K Sell
384
-4,785
-93% -$61.4K ﹤0.01% 6216
2016
Q1
$70K Sell
5,169
-5,759
-53% -$73.4K ﹤0.01% 5478
2015
Q4
$241K Buy
10,928
+5,786
+113% +$125K ﹤0.01% 4993
2015
Q3
$100K Sell
5,142
-9,294
-64% -$211K ﹤0.01% 5425
2015
Q2
$345K Buy
14,436
+4,436
+44% +$104K ﹤0.01% 4944
2015
Q1
$191K Hold
10,000
﹤0.01% 5229
2014
Q4
$79K Sell
10,000
-781
-7% -$7.62K ﹤0.01% 5648
2014
Q3
$158K Sell
10,781
-1,289
-11% -$20K ﹤0.01% 5264
2014
Q2
$220K Sell
12,070
-3,618
-23% -$50.8K ﹤0.01% 5102
2014
Q1
$208K Buy
15,688
+12,098
+337% +$211K ﹤0.01% 5097
2013
Q4
$62K Buy
+3,590
New +$54.3K ﹤0.01% 5519

Other funds holding DRRX

Morgan Stanley's DRRX Position: Q3 2025 in Review

Morgan Stanley sold out of DURECT Corp (DRRX) in Q3 2025, closing a stake of 500 shares — an estimated $318 sold.

Morgan Stanley first reported a position in DRRX in Q4 2013 and held it in 46 quarters. The position peaked at $1.13M in Q1 2018. 2 funds tracked by Wall St. Rank hold DRRX as of Q3 2025.

  • Morgan Stanley reported no remaining DURECT Corp position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 500 DURECT Corp shares in Q3 2025, an estimated $318.
  • Morgan Stanley first reported a position in DURECT Corp in Q4 2013 and held it in 46 quarters.
  • Morgan Stanley's DURECT Corp position peaked at $1.13M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held DURECT Corp as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.